Nov 14, 2014 | Digital Pathology, Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology
Developers seeking FDA Approval for microchip-based nanotechnology type-1 diabetes test, which has been performed on people with accurate results
New nanotechnology has made it possible for a team at Stanford University School of Medicine to develop a medical laboratory test for type-1 diabetes that can be performed in a physician’s office and does not require a specimen collected by venipuncture.
This microchip requires just minutes to diagnose type-1 diabetes in near-patient settings, according to a Stanford University news release. (more…)
May 17, 2013 | Digital Pathology, Instruments & Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Pathology
Pathologists will want to engage with physicians as wireless devices and smartphone apps make it possible to maintain continuous surveillance of the body
Pathologists might want to borrow a page from a tech-savvy doctor who was voted the “Most Influential Physician Executive” in 2012. A cardiologist, this physician says he now prescribes mobile applications for his patients almost as frequently as he prescribes therapeutic drugs.
Many clinical laboratory managers will recognize the name of Eric Topol, M.D., who is the Director of the Scripps Translational Science Institute, Professor of Genomics at the Scripps Research Institute, and Chief Academic Officer at Scripps Health, all located in La Jolla, California. Topol has a passion for wireless medical technology. Moreover, he is nationally recognized as a wireless medical technology trailblazer, as well as for his medical expertise.
In fact, in one news clip, NBC News touts him as the nation’s foremost expert in the explosion of wireless medicine. Topol was also selected by GQ Magazine in 2009 as one of the nation’s 12 “Rock Stars of Science.” (more…)
Apr 26, 2013 | Instruments & Equipment, Laboratory News, Laboratory Pathology
Pathologists and clinical laboratory managers may want to learn more about the UCheck mobile app developed by Biosense Technologies
Developers of a new iPhone application claim their app can analyze a urine specimen for up to 25 different diseases. This mobile app is a deliberate attempt to give consumers the ability to perform diagnostic tests that would normally be run in a full-scale clinical laboratory.
Pathologists and clinical biochemists will want to visit the website of Biosense Technologies to check out this mobile application, which is called uCheck. Biosense is a medical device company located in Mumbai, India. (more…)
Jan 14, 2013 | Digital Pathology, Instruments & Equipment, Laboratory Hiring & Human Resources, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology
Growth in global IVD markets is indicator of increasing demand for clinical laboratory and anatomic pathology testing
During the next 24 months, the global in vitro diagnostics (IVD) market is predicted to exceed $50-billion in revenues. However, this robust growth has an upside and a downside for the clinical laboratories and pathology groups that purchase IVD analyzers, reagents, and consumables.
In a recent story in about the IVD industry, Frost & Sullivan, a global consulting and research firm, made predictions in different segments of the IVD market. It won’t surprise pathologists and clinical laboratory managers that the two fastest-growing segments are molecular and tissue diagnostics. (more…)
Dec 5, 2011 | Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Managed Care Contracts & Payer Reimbursement, Management & Operations
New report determines in-home patient care can save an average of 22% over inpatient care for six different health conditions
Momentum continues to build in favor of the “Hospital in the Home”, known by the acronym HITH. For certain health conditions, this care model allows the patient to remain in his or her home, instead of staying in a hospital. Caregivers, including specialist physicians, come to the residence with almost the same frequency as occurs for hospital inpatients.
Wider adoption of this model of patient care would directly affect pathologists and clinical laboratory managers who work in hospital laboratories. Over time, it could mean fewer inpatient admissions and thus, less medical laboratory test volumes for inpatient services. On the other hand, more HITH patients would increase the need to collect specimens in patient’s homes and get them to a local clinical laboratory for testing. Hospital-based medical laboratories—because they are central to the communities they serve—would be well-positioned to provide this diagnostic testing.
(more…)
